Back to News
Market Impact: 0.35

Cal-Maine Vs Vital Farms: Which Egg Stock Should Be in Your Basket?

CALMNDAQVITL
Commodities & Raw MaterialsCorporate EarningsCompany FundamentalsAnalyst EstimatesConsumer Demand & RetailCapital Returns (Dividends / Buybacks)M&A & Restructuring
Cal-Maine Vs Vital Farms: Which Egg Stock Should Be in Your Basket?

An analysis comparing Cal-Maine Foods (CALM) and Vital Farms (VITL) highlights Cal-Maine as the more compelling investment due to its Strong Buy Zacks Rank, cheaper valuation (16.00x forward earnings vs. Vital Farms' 24.59x), higher return on equity (48.72% vs 19.53%), and a 14.7% dividend yield. While both companies navigate shifting consumer preferences and recent egg price volatility due to avian influenza outbreaks, Cal-Maine's strategic acquisitions and expansion into cage-free and value-added products, coupled with rising earnings estimates, position it favorably despite an expected earnings decline in fiscal year 2026.

Analysis

The U.S. egg industry is navigating significant price volatility due to highly pathogenic avian influenza (HPAI) outbreaks, which led to the depopulation of 40.2 million birds in 2024 and an additional 33.5 million year-to-date in 2025, according to the USDA; however, egg prices have recently moderated amid improved supply prospects. Demand for eggs remains resilient, supported by their perception as a high-quality protein source and increasing consumer preference for ethically and sustainably produced options, particularly cage-free and pasture-raised eggs. Cal-Maine Foods (CALM), the largest U.S. shell egg producer, demonstrated strong performance in its third-quarter fiscal 2025 (ended March 1, 2025), with revenues surging 102% year-over-year to $1.42 billion and earnings per share reaching $10.38, up from $3.00 in the prior-year quarter, driven by higher net average selling prices and increased volumes, while farm production costs per dozen declined 5.7% year-over-year. CALM is strategically investing $60 million in capital projects to expand its cage-free capacity by 1.1 million layer hens this year and is diversifying into value-added egg products through acquisitions like Echo Lake Foods. Analyst consensus for CALM projects a 299.5% year-over-year EPS increase to $22.73 for fiscal 2025, followed by an anticipated 74.9% decline to $5.71 in fiscal 2026, though both estimates have seen upward revisions. In contrast, Vital Farms (VITL), a premium pasture-raised egg brand, reported a 9.6% revenue increase to $148 million in its first quarter of fiscal 2025 (ended March 31, 2025), but its earnings per share decreased 14% year-over-year to 37 cents, mainly due to increased investments in personnel. VITL aims to reach $1 billion in net revenues by 2027 with an adjusted EBITDA margin of 12-14%, supported by an expanding network of 450 family farms and product availability in 26,000 retail stores. Financially, CALM's stock has gained 57.6% in the past year, trades at a forward 12-month P/E of 16.00x, exhibits a return on equity (ROE) of 48.72%, and offers a 14.7% dividend yield. Conversely, VITL's stock has declined 18% over the past year, trades at a higher forward P/E of 24.59x, has an ROE of 19.53%, and does not pay a dividend.